Allergy Clinical Trial
Official title:
Importance of Hand Washing After Each NAET® Treatment
Background: It has been suspected in our clinic patients that when patients do not wash
their hands after receiving NAET treatments, the effect of their treatments has been reduced
or in some cases, the same treatment has to be repeated more times to be effective.
Location of the study: PNIB Research Center 6714 Beach Blvd. Buena Park, CA 90621
Purpose The purpose of the study was to determine the importance of hand-washing with plain
water after each NAET® treatment. The study utilized an experimental design with random
assignment to two groups, consisting of treatment/experimental, and treatment/control
groups.
Objective: We sought to determine if there is any benefit to mandate hand-washing with plain
water after each NAET® treatment.
Selection of the Subjects:
The study was limited to the established patients in our clinic who came for NAET treatments
on a Wednesday. Wednesday was chosen since it was a full working day and more patients will
be treated on Wednesdays. First patient who arrived in the office was assigned into the
experimental/treating group, then every odd number was selected as treating group. All even
numbers were selected as placebo group..
Inclusion Criteria The primary inclusion criterion was that patients are getting treated for
NAET on that day. All new patients were excluded. Only existing patients were chosen for
this study. All the subjects included were required to sign a consent form, which allowed
the researcher to designate them as subjects for the study.
Exclusion Criteria The exclusion criteria were: Serious illness, e.g., cancer, chronic
obstructive pulmonary diseases, kidney diseases, heart diseases, pregnancy, mental diseases,
and history of anaphylaxis.
Group Assignments:
38 females, and 22 males ages ranged between 12-60 years were randomly assigned to 2 groups:
1. Experimental group: 30 (22 females and 8 males) subjects were assigned to this group.
2. Control group: 30 (16 females and 14 males) subjects were assigned to this group.
Experimental Subjects:
They were advised to wash their hands with soap and water before beginning of NAET
treatments. They were also asked to wash their hands with plain water (no soap) after
completing NAET treatment before they left the office.
Control group:
They were advised not to wash their hands before or after the NAET treatment. They were
allowed to go home soon after the treatment.
Evaluation Methods:
All subjects were treated for their appropriate scheduled allergens for that day. After the
NAET, they waited for 20 minutes in the office. Then they were rechecked for the treated
allergens. All of them had successfully completed their treatments. The experimental group
was advised to wash their hands with plain water and they were advised to go home. The
control group was advised to go home without washing their hands with water. They were asked
to return on the following Wednesday for reexamination. A week after the treatment, they all
returned for recheck and the resuls were recorded.
Duration of The Study The study duration was 7 days.
Results:
Experimental Group: 28 passed the treatment. 2 failed the treatment. Control Group: 5 passed
the treatment. 25 failed the treatment. NAET Treatment was successful in 93.3% of the
experimental group who utilized hand-washing after NAET treatment. NAET Treatment was
successful 16.6% in the control group who did not wash their hands after NAET treatment.
Conclusion: The study concluded that hand-washing with plain water after each NAET treatment
is essential for completing NAET treatments successfully.
Reprints Request from:
NAR Foundation 6714-32 Beach Blvd. Buena Park, CA 90621 narfoundation@yahoo.com
;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Educational/Counseling/Training
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02032056 -
Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period
|
N/A | |
| Completed |
NCT01842711 -
Cumulative Irritation Patch Test
|
N/A | |
| Completed |
NCT01633840 -
New Validated Recipes for Double-blind Placebo-controlled Low Dose Food Challenges
|
N/A | |
| Completed |
NCT00554983 -
Efficacy and Safety From a Recombinant Folding Variant of Bet v 1
|
Phase 3 | |
| Completed |
NCT00997971 -
Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein
|
Phase 3 | |
| Completed |
NCT00331929 -
Respiratory Health Study of Children in Kiryat Tivon
|
N/A | |
| Completed |
NCT00220753 -
Air Cleaners for Children and Adolescents With Asthma and Dog Allergy
|
N/A | |
| Completed |
NCT00232518 -
Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis
|
N/A | |
| Completed |
NCT04046731 -
Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation
|
N/A | |
| Completed |
NCT04126096 -
Negative Predictive Value and NIC of Beta-Lactam Antibiotics.
|
N/A | |
| Completed |
NCT04004351 -
Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma
|
||
| Not yet recruiting |
NCT05997784 -
Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing
|
||
| Completed |
NCT04418999 -
Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
|
Early Phase 1 | |
| Completed |
NCT04186949 -
Early Origins of Allergy and Asthma
|
||
| Completed |
NCT02127801 -
Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants
|
Phase 1 | |
| Enrolling by invitation |
NCT05011071 -
The Alberta BLOOM Premature Child Study
|
||
| Not yet recruiting |
NCT06330974 -
Allergy, Asthma, and Atopic Eczema in Finland
|
||
| Completed |
NCT02306473 -
The Leaky Lung Test
|
Early Phase 1 | |
| Completed |
NCT02596321 -
A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma
|
Phase 3 | |
| Terminated |
NCT02601690 -
Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America
|